Smart Ring Maker Oura, Backers Seek $2.2 Billion in US IPO

Coinbase launched a new service allowing eligible U.S. retail customers to request allocations in IPOs, starting with Oura's $2.2B IPO. Oura plans to sell 13.5M shares at $40-$44 each, with a fully diluted valuation of about $15.62B. Coinbase's IPO access prioritizes long-term investors, discouraging early selling.

Oura Inc, a smart ring maker, aims to raise $2.2B in a US IPO, offering 50M shares at $40-$44 each. The company could be valued at $14.1B-$15B. Oura reported a $924.3M net loss on $1.21B revenue for the nine months ended June 30. The IPO is expected to price on September 29, with shares trading on Nasdaq under ticker OURA.

Coinbase launched a feature allowing eligible US retail customers to request IPO shares, starting with Oura. Oura plans to offer 13.5M shares priced between $40 and $44, listing on Nasdaq as OURA. Coinbase's stock (COIN) rose 3.5% to $201.05 on the news, with a market cap of $53.04B. Oura's IPO is expected to price this week.

Oura, a smart ring maker, is targeting a $15.62B valuation in its upcoming IPO, selling 50M shares at $40-$44 each. The company sold 3.6M rings in the past year, with revenue up 74% YoY to $1.21B. Eli Lilly and Dragoneer have shown interest in purchasing shares. Oura aims to list on Nasdaq under 'OURA'.

Oura, a health-tracking smart ring maker, aims to raise $2.2B in a U.S. IPO, offering 50M shares at $40-$44 each. The company reported $1.21B revenue and 5M paid members as of June 30, with a net loss of $924.3M. Existing shareholders will sell most shares, with a market cap potentially reaching $14.1B.

Oura Health launched its IPO, aiming to raise $2.2B by selling 50M shares at $40-$44 each, targeting a $15.62B valuation. Trading under 'OURA' on Nasdaq, it sold 3.6M rings in the past year with $1.21B revenue. Eli Lilly and Dragoneer may invest $100M and $300M respectively. The company faces a lawsuit over sleep tracking accuracy claims.